Download PDF
Semin Neurol 2012; 32(02): 161-168
DOI: 10.1055/s-0032-1322582
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Management of Chronic Myelopathy Symptoms and Activities of Daily Living

Karunesh Ganguly
1   San Francisco VA Medical Center, University of California, San Francisco, California
2   Department of Neurology, University of California, San Francisco, California
,
Gary M. Abrams
1   San Francisco VA Medical Center, University of California, San Francisco, California
2   Department of Neurology, University of California, San Francisco, California
3   Department of Rehabilitation Service, University of California, San Francisco, California
› Author Affiliations
Further Information

Publication History

Publication Date:
08 September 2012 (online)

    Permissions and Reprints

Abstract

Many disorders can injure the spinal cord resulting in long-term chronic myelopathy. Spinal cord dysfunction influences the homeostasis of multiple organ systems ranging from the heart or lung to the integument, thus presenting a wide variety of challenges for medical management. Although most of our knowledge about the consequences of myelopathies derives from the study of traumatic spinal cord injuries, similar complications occur in myelopathies of all etiologies. The authors survey some of the important clinical issues that the general neurologist needs to consider in caring for patients with chronic spinal cord disease.

Keywords

myelopathy - spinal cord injury - spasticity - pain
 

  • References

  • 1 McKinley WO, Seel RT, Hardman JT. Nontraumatic spinal cord injury: incidence, epidemiology, and functional outcome. Arch Phys Med Rehabil 1999; 80 (6) 619-623
    CrossrefPubMedGoogle Scholar
  • 2 McKinley WO, Tewksbury MA, Godbout CJ. Comparison of medical complications following nontraumatic and traumatic spinal cord injury. J Spinal Cord Med 2002; 25 (2) 88-93
    PubMedGoogle Scholar
  • 3 Gupta A, Taly AB, Srivastava A, Murali T. Non-traumatic spinal cord lesions: epidemiology, complications, neurological and functional outcome of rehabilitation. Spinal Cord 2009; 47 (4) 307-311
    CrossrefPubMedGoogle Scholar
  • 4 Bycroft J, Shergill IS, Chung EAL, Arya N, Shah PJ. Autonomic dysreflexia: a medical emergency. Postgrad Med J 2005; 81 (954) 232-235
    CrossrefPubMedGoogle Scholar
  • 5 Karlsson AK. Autonomic dysreflexia. Spinal Cord 1999; 37 (6) 383-391
    CrossrefPubMedGoogle Scholar
  • 6 Furlan JC, Fehlings MG, Halliday W, Krassioukov AV. Autonomic dysreflexia associated with intramedullary astrocytoma of the spinal cord. Lancet Oncol 2003; 4 (9) 574-575
    CrossrefPubMedGoogle Scholar
  • 7 Finestone HM, Teasell RW. Autonomic dysreflexia after brainstem tumor resection. A case report. Am J Phys Med Rehabil 1993; 72 (6) 395-397
    PubMedGoogle Scholar
  • 8 Bateman AM, Goldish GD. Autonomic dysreflexia in multiple sclerosis. J Spinal Cord Med 2002; 25 (1) 40-42
    PubMedGoogle Scholar
  • 9 Phillips SM, Stewart BG, Mahoney DJ , et al. Body-weight-support treadmill training improves blood glucose regulation in persons with incomplete spinal cord injury. J Appl Physiol 2004; 97 (2) 716-724
    CrossrefPubMedGoogle Scholar
  • 10 van Hedel HJ, Dietz V. Rehabilitation of locomotion after spinal cord injury. Restor Neurol Neurosci 2010; 28 (1) 123-134
    PubMedGoogle Scholar
  • 11 Myers J, Lee M, Kiratli J. Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management. Am J Phys Med Rehabil 2007; 86 (2) 142-152
    CrossrefPubMedGoogle Scholar
  • 12 Green D, Hull RD, Mammen EF, Merli GJ, Weingarden SI, Yao JS. Deep vein thrombosis in spinal cord injury. Summary and recommendations. Chest 1992; 102 (6, Suppl) 633S-635S
    PubMedGoogle Scholar
  • 13 Ageno W, Agnelli G, Checchia G , et al; Italian Society for Haemostasis and Thrombosis. Prevention of venous thromboembolism in immobilized neurological patients: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2009; 124 (5) e26-e31
    CrossrefPubMedGoogle Scholar
  • 14 Scivoletto G, Cosentino E, Morganti B, Farchi S, Molinari M. Clinical prognostic factors for bladder function recovery of patients with spinal cord and cauda equina lesions. Disabil Rehabil 2008; 30 (5) 330-337
    CrossrefPubMedGoogle Scholar
  • 15 Kay E, Deutsch A, Chen D , et al. Effects of etiology on inpatient rehabilitation outcomes in 65–74 year-old patients with incomplete paraplegia from a nontraumatic spinal cord injury. PM R 2010; 2 (6) 504-513
    CrossrefPubMedGoogle Scholar
  • 16 Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci 2008; 9 (6) 453-466
    CrossrefPubMedGoogle Scholar
  • 17 Linsemeyer T, Bodner D, Creasey G , et al; Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. J Spinal Cord Med 2006; 29 (5) 527-573
    PubMedGoogle Scholar
  • 18 Kalsi V, Gonzales G, Popat R , et al. Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol 2007; 62 (5) 452-457
    CrossrefPubMedGoogle Scholar
  • 19 Khan S, Game X, Kalsi V , et al. Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis. J Urol 2011; 185 (4) 1344-1349
    CrossrefPubMedGoogle Scholar
  • 20 Morton SC, Shekelle PG, Adams JL , et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002; 83 (1) 129-138
    CrossrefPubMedGoogle Scholar
  • 21 Katalinic OM, Harvey LA, Herbert RD, Moseley AM, Lannin NA, Schurr K. Stretch for the treatment and prevention of contractures. Cochrane Database Syst Rev 2010; 8 (9) CD007455
    PubMedGoogle Scholar
  • 22 Paralyzed Veterans of America Consortium for Spinal Cord Medicine. Preservation of upper limb function following spinal cord injury: a clinical practice guideline for health-care professionals. J Spinal Cord Med 2005; 28 (5) 434-470
    PubMedGoogle Scholar
  • 23 Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol 2010; 162 (6) 1009-1020
    CrossrefPubMedGoogle Scholar
  • 24 Zorzon M, Zivadinov R, Locatelli L , et al. Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. Eur J Neurol 2005; 12: 550-556
    CrossrefPubMedGoogle Scholar
  • 25 Bryson JE, Gourlay ML. Bisphosphonate use in acute and chronic spinal cord injury: a systematic review. J Spinal Cord Med 2009; 32 (3) 215-225
    PubMedGoogle Scholar
  • 26 Teasell RW, Mehta S, Aubut JL , et al; SCIRE Research Team. A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury. Spinal Cord 2010; 48 (7) 512-521
    CrossrefPubMedGoogle Scholar
  • 27 Taly AB, Nair KP, Kumar MV , et al. Heterotopic ossification in non-traumatic myelopathies. Spinal Cord 1999; 37 (1) 47-49
    CrossrefPubMedGoogle Scholar
  • 28 Schuetz P, Mueller B, Christ-Crain M, Dick W, Haas H. Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases. Spinal Cord 2005; 43 (10) 604-610
    CrossrefPubMedGoogle Scholar
  • 29 Stechmiller JK, Cowan L, Whitney JD , et al. Guidelines for the prevention of pressure ulcers. Wound Repair Regen 2008; 16 (2) 151-168
    CrossrefPubMedGoogle Scholar
  • 30 Maynard FM, Karunas RS, Waring III WP. Epidemiology of spasticity following traumatic spinal cord injury. Arch Phys Med Rehabil 1990; 71 (8) 566-569
    PubMedGoogle Scholar
  • 31 Taricco M, Adone R, Pagliacci C, Telaro E. Pharmacological interventions for spasticity following spinal cord injury. Cochrane Database Syst Rev 2000; (2) CD001131
    PubMedGoogle Scholar
  • 32 Thompson AJ, Jarrett L, Lockley L, Marsden J, Stevenson VL. Clinical management of spasticity. J Neurol Neurosurg Psychiatry 2005; 76 (4) 459-463
    CrossrefPubMedGoogle Scholar
  • 33 Smania N, Picelli A, Munari D , et al. Rehabilitation procedures in the management of spasticity. Eur J Phys Rehabil Med 2010; 46 (3) 423-438
    PubMedGoogle Scholar
  • 34 Marciniak C, Rader L, Gagnon C. The use of botulinum toxin for spasticity after spinal cord injury. Am J Phys Med Rehabil 2008; 87 (4) 312-317 , quiz 318–320, 329
    CrossrefPubMedGoogle Scholar
  • 35 Bovend'Eerdt TJ, Newman M, Barker K, Dawes H, Minelli C, Wade DT. The effects of stretching in spasticity: a systematic review. Arch Phys Med Rehabil 2008; 89 (7) 1395-1406
    CrossrefPubMedGoogle Scholar
  • 36 Santamato A, Panza F, Ranieri M , et al. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report. J Rehabil Med 2010; 42 (9) 891-894
    CrossrefPubMedGoogle Scholar
  • 37 Nair KPS, Taly AB, Maheshwarappa BM, Kumar J, Murali T, Rao S. Nontraumatic spinal cord lesions: a prospective study of medical complications during in-patient rehabilitation. Spinal Cord 2005; 43 (9) 558-564
    CrossrefPubMedGoogle Scholar
  • 38 Werhagen L, Hultling C, Molander C. The prevalence of neuropathic pain after non-traumatic spinal cord lesion. Spinal Cord 2007; 45 (9) 609-615
    CrossrefPubMedGoogle Scholar
  • 39 Finnerup NB, Jensen TS. Spinal cord injury pain—mechanisms and treatment. Eur J Neurol 2004; 11 (2) 73-82
    CrossrefPubMedGoogle Scholar
  • 40 Cardenas DD, Felix ER. Pain after spinal cord injury: a review of classification, mechanisms, treatment approaches and treatment assessment. PM R 2009; 1: 1077-1090
    CrossrefPubMedGoogle Scholar
  • 41 Wasner G, Lee BB, Engel S, McLachlan E. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. Brain 2008; 131 (Pt 9) 2387-2400
    CrossrefPubMedGoogle Scholar
  • 42 Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150 (3) 573-581
    Google Scholar
  • 43 Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 2006; 67 (10) 1792-1800
    CrossrefPubMedGoogle Scholar
  • 44 Rintala DH, Holmes SA, Courtade D, Fiess RN, Tastard LV, Loubser PG. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil 2007; 88 (12) 1547-1560
    CrossrefPubMedGoogle Scholar
  • 45 Cardenas DD, Jensen MP. Treatments for chronic pain in persons with spinal cord injury: A survey study. J Spinal Cord Med 2006; 29 (2) 109-117
    PubMedGoogle Scholar
  • 46 Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352 (13) 1324-1334
    CrossrefPubMedGoogle Scholar
  • 47 Norrbrink C, Lundeberg T. Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial. Clin J Pain 2009; 25 (3) 177-184
    CrossrefPubMedGoogle Scholar
  • 48 Sturt RN, Holland AE, New PW. Walking ability at discharge from inpatient rehabilitation in a cohort of non-traumatic spinal cord injury patients. Spinal Cord 2009; 47 (10) 763-768
    CrossrefPubMedGoogle Scholar
  • 49 McKinley W, Merrell C, Meade M, Brooke K, DiNicola A. Rehabilitation outcomes after infection-related spinal cord disease: a retrospective analysis. Am J Phys Med Rehabil 2008; 87 (4) 275-280
    CrossrefPubMedGoogle Scholar
  • 50 Consortium for Spinal Cord Medicine. Outcomes following traumatic spinal cord injury: clinical practice guidelines for health-care professionals. J Spinal Cord Med 2000; 23 (4) 289-316
    PubMedGoogle Scholar
  • 51 Kiyono Y, Hashizume C, Matsui N, Ohtsuka K, Takaoka K. Car-driving abilities of people with tetraplegia. Arch Phys Med Rehabil 2001; 82 (10) 1389-1392
    PubMedGoogle Scholar
  • 52 Shurrager PS, Dykman RA. Walking spinal carnivores. J Comp Physiol Psychol 1951; 44 (3) 252-262
    CrossrefPubMedGoogle Scholar
  • 53 Wolpaw JR. Treadmill training after spinal cord injury: good but not better. Neurology 2006; 66 (4) 466-467
    CrossrefPubMedGoogle Scholar
  • 54 Wirz M, Colombo G, Dietz V. Long term effects of locomotor training in spinal humans. J Neurol Neurosurg Psychiatry 2001; 71 (1) 93-96
    CrossrefPubMedGoogle Scholar
  • 55 Hesse S, Schmidt H, Werner C, Bardeleben A. Upper and lower extremity robotic devices for rehabilitation and for studying motor control. Curr Opin Neurol 2003; 16 (6) 705-710
    CrossrefPubMedGoogle Scholar
  • 56 Wessels M, Lucas C, Eriks I, de Groot S. Body weight-supported gait training for restoration of walking in people with an incomplete spinal cord injury: a systematic review. J Rehabil Med 2010; 42 (6) 513-519
    CrossrefPubMedGoogle Scholar
  • 57 Mehrholz J, Kugler J, Pohl M. Locomotor training for walking after spinal cord injury. Spine (Phila Pa 1979) 2008; 33 (21) E768-E777
    CrossrefPubMedGoogle Scholar
  • 58 van Hedel HJ. Weight-supported treadmill versus over-ground training after spinal cord injury: from a physical therapist's point of view. Phys Ther 2006; 86 (10) 1444-1445 , author reply 1445–1447
    CrossrefPubMedGoogle Scholar
  • 59 Nicolelis MA, Lebedev MA. Principles of neural ensemble physiology underlying the operation of brain-machine interfaces. Nat Rev Neurosci 2009; 10 (7) 530-540
    CrossrefPubMedGoogle Scholar
  • 60 Schwartz AB. Cortical neural prosthetics. Annu Rev Neurosci 2004; 27: 487-507
    CrossrefPubMedGoogle Scholar
  • 61 Hochberg LR, Serruya MD, Friehs GM , et al. Neuronal ensemble control of prosthetic devices by a human with tetraplegia. Nature 2006; 442 (7099) 164-171
    CrossrefPubMedGoogle Scholar
  • 62 Ganguly K, Carmena JM. Emergence of a stable cortical map for neuroprosthetic control. PLoS Biol 2009; 7 (7) e1000153
    CrossrefPubMedGoogle Scholar
  • 63 Velliste M, Perel S, Spalding MC, Whitford AS, Schwartz AB. Cortical control of a prosthetic arm for self-feeding. Nature 2008; 453 (7198) 1098-1101
    CrossrefPubMedGoogle Scholar